Abstract
This study examines 1999 data from Medstat's MarketScan® database of privately insured employees of US firms and their dependents. Of enrolled children and adolescents ages 2–18, 6.6% had claims for mental health services. Average outpatient expenditures per user were $651. Of children/adolescents with claims for mental health services (MH claimants), 3.4% had inpatient MH services, with an average length of stay of 8.9 days and average MH-related inpatient expenditure per user of $7,048. One half of MH claimants who had pharmacy benefit data had claims for psychotropic medications, with average expenditures per user of $328. Whereas children/adolescent mental health users comprised 8.3% of all service users, expenditures for their care were 20.5% of all service expenditures for children/adolescents in private health plans. Results also highlight the importance of including data on psychotropic medication in analysis of children's MH services utilization, as well as the need to consider the use of psychotropic medications among children/adolescents who do not utilize other MH services.
Similar content being viewed by others
Notes
POS plans include HMO products where the beneficiary can choose medical services within the plan's network or seek care outside the network for additional out-of-pocket expenses.
Of 34,500 children/adolescents with MH service use, 17,298 also received a psychotropic medication.
References
Burns BJ. Mental health service use by adolescents in the 1970s and 1980s. Journal of American Academy of Child and Adolescent Psychiatry. 1991;30(1):144–150.
Insurance coverage of mental health and substance abuse services for children and adolescents: A consensus statement. American Academy of Pediatrics. Pediatrics. 2000;106(4):860–862.
Elixhauser A, Machlin SR, Zodet MW, et al. Health care for children and youth in the United States: 2001 annual report on access, utilization, quality, and expenditures. Ambulatory Pediatrics. 2002;2(6):419–437.
Glied S, Hoven CW, Moore RE, et al. Children's access to mental health care: does insurance matter? Health Affairs (Millwood). 1997;16(1):167–174.
Ringel JS, Sturm R. National estimates of mental health utilization and expenditures for children in 1998. Journal of Behavioral Health Services Research. 2001;28(3):319–333.
Leslie DL, Rosenheck RA, Horwitz SM. Patterns of mental health utilization and costs among children in a privately insured population. Health Services Research. 2001;36(1 Pt 1):113–127.
Mark TL, Coffey RM. What drove private health insurance spending on mental health and substance abuse care, 1992–1999? Health Affairs (Millwood). 2003;22(1):165–172.
Harwood HJ, Mark TL, McKusick DR, et al. National spending on mental health and substance abuse treatment by age of clients, 1997. Journal of Behavioral Health Services Research. 2003;30(4):433–443.
Harpaz-Rotem I, Rosenheck RA. Changes in outpatient psychiatric diagnosis in privately insured children and adolescents from 1995 to 2000. Child Psychiatry and Human Development. 2004;34(4):329–340.
Olfson M, Gameroff MJ, Marcus SC, et al. Outpatient treatment of child and adolescent depression in the United States. Archives of General Psychiatry. 2003;60(12):1236–1242.
Zito JM, Safer DJ, DosReis S, et al. Trends in the prescribing of psychotropic medications to preschoolers. Journal of American Medical Association. 2000;283(8):1025–1030.
Zito JM, Safer DJ, DosReis S, et al. Psychotropic practice patterns for youth: a 10-year perspective. Archives of Pediatric and Adolescent Medicine. 2003;157(1):17–25.
Wilens TE. Straight Talk about Psychiatric Medications for Kids. New York: The Guilford Press; 1999.
Jensen PS, Bhatara VS, Vitiello B, et al. Psychoactive medication prescribing practices for U.S. children: gaps between research and clinical practice. Journal of the American Academy of Child and Adolescent Psychiatry. 1999;38(5):557–565.
Everitt IJ, Barnett P. Comparison of two benzodiazepines used for sedation of children undergoing suturing of a laceration in an emergency department. Pediatric Emergency Care. 2002;18(2):72–74.
Houpt M. Project USAP 2000—Use of sedative agents by pediatric dentists: a 15-year follow-up survey. Pediatric Dentistry. 2002;24(4):289–294.
Stein BD, Sturm R, Kapur K, et al. Datapoints: psychotropic medication costs among youth with private insurance in 1998. Psychiatric Services. 2001;52(2):152.
PDR Drug Guide for Mental Health Professionals—First Edition. Montvale, NJ: Thomson Medical Economics; 2002.
Author information
Authors and Affiliations
Corresponding author
Additional information
Kay Miller, BA, Medstat, Santa Barbara, CA 93111-2348, USA.
Kathleen J. Fleming, MEd, CAGS, New England Research Institutes, Watertown, MA 02472, USA.
Judith L. Teich, MSW, Center for Mental Health Services, Substance Abuse and Mental Health Services Administration, Rockville, MD 20857, USA.
Rights and permissions
About this article
Cite this article
Larson, M.J., Miller, K., Fleming, K.J. et al. Mental Health Services for Children in Large, Employer-Based Health Plans, 1999. J Behav Health Serv Res 34, 56–72 (2007). https://doi.org/10.1007/s11414-006-9028-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11414-006-9028-0